1. Patients launch $1.27 million crowdfunding campaign for ME/CFS gut microbiome study.
    Check out the website, Facebook and Twitter. Join in donate and spread the word!
Nitric oxide and its possible implication in ME/CFS (Part 1 of 2)
Andrew Gladman explores the current and historic hypotheses relating to nitric oxide problems in ME/CFS. Part 1 of a 2-part series puts nitric oxide under the microscope and explores what it is, what it does and why it is so frequently discussed in the world of ME/CFS. Part 1 focuses...
Discuss the article on the Forums.

Astounding Norwegian research breakthrough with Rituximab can solve CFS mystery!!!

Discussion in 'Rituximab: News and Research' started by urbantravels, Oct 19, 2011.

  1. Battery Muncher

    Battery Muncher Senior Member

    Messages:
    182
    Likes:
    136
    Good post. Just to add to this - at the start of this thread, wasn't it mentioned that Mikovits was present when Mella and Fluge first presented their results? Surely she would have spoken out if she felt her research was stolen.

    I'm afraid that I don't know anything re IrsiCaixa.
  2. redo

    redo Senior Member

    Messages:
    830
    Likes:
    89
    Yes, of course it's not "stolen". Fluge and Mella had their first patient on Rituximab over four years ago. Than they applied for ethics approval for the three patient case study sometime in 2007. The patients than was on Rituximab and obervation. One for over 1.5 years. Than they wrote the text for the case study. Than the sent it for publication, and it was received in May 2009. Than, almost a half year after that occurred, the XMRV study got published.
  3. barbc56

    barbc56 Senior Member

    Messages:
    1,365
    Likes:
    724
    I have heard about cancer/me/cfs patients feeling better after chemotherapy for years. All anecdotal/hearsay reports, of course. It will be interesting to see how this plays out.

    What ever happened to the research at George Washington University about proteins in the spinal fluid of PWMECFS? I was going to participate in that study but guess what. Didn't have the energy to participate.

    I can't think of the Doctor's name but will look for it and post it later. I do know he was at one of the important conferences. If I find my brain, that is. :>)
  4. leela

    leela Slow But Hopeful

    Messages:
    2,377
    Likes:
    2,754
    Couchland, USA
    Wasn't it Dr Baraniuk?
    My brain not fully operational either, so I could be wrong...
  5. currer

    currer Senior Member

    Messages:
    1,324
    Likes:
    773
    http://www.retrovirology.com/content/8/S1/A230

    Hi Mark.

    The above link is the paper you are interested in where Mikovits and Ruscetti look at the CD20 B cells and find XMRV in them.

    I agree that the rituximab studies were planned quite independently of Dr Mikovits research, however she could be credited with helping to change the political stance on ME, as she did go over to Norway at a time when her XMRV research was getting massive publicity.

    This, by itself, would make the Norwegians aware of the ME problem.

    We have to be grateful to Dr Mikovits for always being a wholehearted advocate for people with ME and raising awareness of the severity of this disorder and the need for proper treatment and care. This would have been well publicised while she was in Norway.

    I think it was pure chance that these researchers, acting independently of each other, both came to focus their attention on these immune cells.

    But the co-incidence is significant.
    Battery Muncher likes this.
  6. currer

    currer Senior Member

    Messages:
    1,324
    Likes:
    773
    Well remembered Mark.

    Here is the Irsi Caixa paper, and yes, they found XMRV in the B cells again.

    I think I must have missed this paper, I have no memory of reading it before.

    http://xmrv.blogspot.com/2010/09/irsi-caixa-finds-xmrv-in-spain.html
    http://forums.phoenixrising.me/show...-Spanish-XMRV-studies&highlight=spanish study
    Did this paper ever get published? Or was it presented only as a poster at the XMRV conference? can anyone remember or find out?
    Why do these papers not get published?

    There is also another paper at the above link by Curriu which discusses the immune abnormalities and dysfunction in ME which ties in with the paper fron Mikovits and Lombardi on the distinct inflammatory signature in XMRV infection.
  7. Battery Muncher

    Battery Muncher Senior Member

    Messages:
    182
    Likes:
    136
    True. When we have someone who works as hard for the ME/CFS community as Mikovits, we should always be grateful.
  8. shannah

    shannah Senior Member

    Messages:
    836
    Likes:
    160
    The ME/CFS study by Mella and Fluge is a key study for our field


    Professor Nancy Klimas, MD, is director at the ME/CFS and Gulf War Illness Research Center as well as Professor of Medicine at University of Miami Miller School of Medicine. She has expressed the following about the ME/CFS study that was recently published:

    The recent study of Drs. ystein Fluge and Olav Mella demonstrating significant improvement in ME/CFS patients treated with the B cell depleting agent Rituximab is a key study for our field.

    By showing that depleting B cells can cause dramatic improvement, the investigators point the field in the direction of autoimmunity, and autoimmunity caused by an autoantibody. However, there is one other plausible explanation: that the B cells were acting as a reservoir of infection and by depleting the B cell line the viral load can be brought down to the point of suppression by the immune system. Because EBV infection is harbored by B cells, as are several other putative latent viruses that could contribute to illness persistence, I believe both of these theories deserve vigorous scientific pursuit.

    Many clinicians fail to realize the severity of the illness that has been termed ME/CFS. This is a profoundly ill population, the severity of illness scores are similar to congestive heart failure and severe rheumatic disorders such as rheumatoid arthritis. If a medication like Rituximab is found to be effective in validation studies, the risk/benefit ratio would justify its use in very ill ME/CFS patients.

    http://bergento.no/the-mecfs-study-by-mella-and-fluge-is-a-key-study-for-our-field/
    Enid, currer and Timaca like this.
  9. Timaca

    Timaca Senior Member

    Messages:
    420
    Likes:
    74
    shannah~ Thanks for posting the link to Dr. Klimas' thoughts.

    Timaca
  10. barbc56

    barbc56 Senior Member

    Messages:
    1,365
    Likes:
    724
    Yes, thank you!!
  11. Tia

    Tia Senior Member

    Messages:
    247
    Likes:
    19

    Aaaahaa! You know, you hit the nail on that one because that girl Elena, who was part of the Norweigan study, she has been well for three years now, since 2008 in fact so maybe that's where Mikovitz got the fact from then? Interesting..

    Ps: And good for us that Elena's stil well..;):D
  12. shannah

    shannah Senior Member

    Messages:
    836
    Likes:
    160
    ME/CFS Alert #12

    Llewellyn King interviews Torsten Potwol on the Norwegian Therapy

    Excerpt from shortly after the 5:00 minute mark:
    ?"they (the Norwegian treating oncologists) claim that these patients (with ME/CFS) are really affected as severely as late stage cancer patients and I think that is something that has not been fully understood by society."

    http://www.youtube.com/user/MECFSAlert#p/u/0/Cv1naaJ4cVY
    madietodd likes this.
  13. sensing progress

    sensing progress Senior Member

    Messages:
    296
    Likes:
    9
    Tucson, AZ
  14. Timaca

    Timaca Senior Member

    Messages:
    420
    Likes:
    74
    madietodd likes this.
  15. Enid

    Enid Senior Member

    Messages:
    3,309
    Likes:
    840
    UK
    Very interesting thanks Timaca -
  16. Esther12

    Esther12 Senior Member

    Messages:
    5,184
    Likes:
    5,182
    Indeed. Thanks Timaca.

    One danger - there were so many little promising hints that seemed to fit with XMRV... and it now seems that they were misleading. Wait and see imo.
  17. Esther12

    Esther12 Senior Member

    Messages:
    5,184
    Likes:
    5,182
    Indeed. Thanks Timaca.

    One danger - there were so many little promising hints that seemed to fit with XMRV... and it now seems that they were misleading. Wait and see imo.
  18. Timaca

    Timaca Senior Member

    Messages:
    420
    Likes:
    74
    Here's the full article: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936947/pdf/keq159.pdf

    I liked this paragraph: on p.1912, just above "Materials and methods": "Our finding clearly show that RA patients having EBV replication at baseline, not only cleared their EBV load, but responded significantly better to the RTX treatment and presented a longer lasting response than patients who do not have EBV replication in the bone marrow.

    I honestly think that within CFS there are subsets of patients who have one or more pathogen making them sick. I'm guessing that Elene got well because the rituximab got rid of her chronic EBV infection: http://bergento.no/?page_id=3242&preview=true

    But, rituximab doesn't work on all infections that may be behind CFS. So, not everyone gets the same amount of benefit from the drug. It is very exciting to me to see these articles.....

    Best, Timaca
    sensing progress likes this.
  19. redo

    redo Senior Member

    Messages:
    830
    Likes:
    89
    +1 Timaca. Great find.
  20. fla

    fla Senior Member

    Messages:
    234
    Likes:
    38
    Montreal, Canada
    Can we expect to see M.E. patients travelling to other countries to get experimental rituximab treatments just like M.S. patients use medical tourism to get experimental stents inserted into their neck veins?

See more popular forum discussions.

Share This Page